Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1989-6-12
|
pubmed:abstractText |
To discriminate the stages of maturation arrest of leukemic B cells, we have investigated the cell surface expression of Fc epsilon RII (H107 antigen) on leukemic B cells from 6 patients with chronic type B-lymphocytic leukemia (B-CLL) by a double staining method combined with cytofluorometry, and their production of soluble Fc epsilon RII by an ELISA technique. Fc epsilon RII was expressed on mu+/delta- cells of case 5 as well as on mu+/delta+ cells of cases 1, 2 and 4, but not on mu+/delta+ cells in cases 3 and 6. The cultivation of leukemic cells with IL-4 not only increased the percentage of Fc epsilon RII+ cells but also enhanced the production of soluble Fc epsilon RII+ in most cases. However, IL-4 had no effects on mu+/delta-/Fc epsilon RII+ cells of case 5, which appeared to correspond to a rather late stage of normal B cell differentiation. Moreover, while leukemic B cells from case 1 spontaneously produced large amounts of soluble Fc epsilon R, the release seemed to be inhibited by an addition of IL-4. From our observations, it is speculated that IgM+/IgD+/Fc epsilon RII- leukemic B cells express surface membrane Fc epsilon RII and produce soluble Fc epsilon RII following stimulation with IL-4, and that IgM+/IgD-/Fc epsilon RII+ B-CLL cells may exist at some late stage of B cell differentiation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Differentiation...,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Fc,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, IgE
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0165-2478
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
323-30
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2523867-Aged,
pubmed-meshheading:2523867-Antigens, Differentiation, B-Lymphocyte,
pubmed-meshheading:2523867-Cell Separation,
pubmed-meshheading:2523867-Dose-Response Relationship, Immunologic,
pubmed-meshheading:2523867-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:2523867-Female,
pubmed-meshheading:2523867-Flow Cytometry,
pubmed-meshheading:2523867-Humans,
pubmed-meshheading:2523867-Interleukin-4,
pubmed-meshheading:2523867-Interleukins,
pubmed-meshheading:2523867-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:2523867-Male,
pubmed-meshheading:2523867-Middle Aged,
pubmed-meshheading:2523867-Receptors, Fc,
pubmed-meshheading:2523867-Receptors, IgE
|
pubmed:year |
1989
|
pubmed:articleTitle |
Heterogeneity in terms of interleukin 4-dependent regulation of Fc epsilon...receptor/CD23 expression on chronic B-lymphocytic leukemia cells.
|
pubmed:affiliation |
Second Division of Internal Medicine, Kyoto University, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|